These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31404055)

  • 1. Five-year Results of a Randomized Controlled Trial for Lumbar Artificial Discs in Single-level Degenerative Disc Disease.
    Yue JJ; Garcia R; Blumenthal S; Coric D; Patel VV; Dinh DH; Buttermann GR; Deutsch H; Miller LE; Persaud EJ; Ferko NC
    Spine (Phila Pa 1976); 2019 Dec; 44(24):1685-1696. PubMed ID: 31404055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar Total Disc Replacement for Discogenic Low Back Pain: Two-year Outcomes of the activL Multicenter Randomized Controlled IDE Clinical Trial.
    Garcia R; Yue JJ; Blumenthal S; Coric D; Patel VV; Leary SP; Dinh DH; Buttermann GR; Deutsch H; Girardi F; Billys J; Miller LE
    Spine (Phila Pa 1976); 2015 Dec; 40(24):1873-81. PubMed ID: 26630435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease: 7-Year Results.
    Radcliff K; Zigler J; Braxton E; Buttermann G; Coric D; Derman P; Garcia R; Jorgensen A; Ferko NC; Situ A; Yue J
    Int J Spine Surg; 2021 Aug; 15(4):612-632. PubMed ID: 34266934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease.
    Shein D; Shue J; Girardi F
    Expert Rev Med Devices; 2016 Dec; 13(12):1069-1072. PubMed ID: 27807981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes.
    McAfee PC; Cunningham B; Holsapple G; Adams K; Blumenthal S; Guyer RD; Dmietriev A; Maxwell JH; Regan JJ; Isaza J
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1576-83; discussion E388-90. PubMed ID: 16025025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 lumbar total disc replacements: results of a prospective, randomized, controlled, multicenter Food and Drug Administration trial with 24-month follow-up.
    Guyer RD; Pettine K; Roh JS; Dimmig TA; Coric D; McAfee PC; Ohnmeiss DD
    Spine (Phila Pa 1976); 2014 May; 39(12):925-31. PubMed ID: 24718066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease.
    Zigler JE; Delamarter RB
    J Neurosurg Spine; 2012 Dec; 17(6):493-501. PubMed ID: 23082846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- to long-term results of total lumbar disc replacement: a prospective analysis with 5- to 10-year follow-up.
    Siepe CJ; Heider F; Wiechert K; Hitzl W; Ishak B; Mayer MH
    Spine J; 2014 Aug; 14(8):1417-31. PubMed ID: 24448028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article.
    Davis RJ; Kim KD; Hisey MS; Hoffman GA; Bae HW; Gaede SE; Rashbaum RF; Nunley PD; Peterson DL; Stokes JK
    J Neurosurg Spine; 2013 Nov; 19(5):532-45. PubMed ID: 24010901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
    Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
    Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clinical Outcomes of 1- and 2-Level Total Disc Replacement: Four-Year Results From a Prospective, Randomized, Controlled, Multicenter IDE Clinical Trial.
    Bae HW; Kim KD; Nunley PD; Jackson RJ; Hisey MS; Davis RJ; Hoffman GA; Gaede SE; Danielson GO; Peterson DL; Stokes JM; Araghi A
    Spine (Phila Pa 1976); 2015 Jun; 40(11):759-66. PubMed ID: 25785955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
    Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
    J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-level total disc replacement with Mobi-C cervical artificial disc versus anterior discectomy and fusion: a prospective, randomized, controlled multicenter clinical trial with 4-year follow-up results.
    Davis RJ; Nunley PD; Kim KD; Hisey MS; Jackson RJ; Bae HW; Hoffman GA; Gaede SE; Danielson GO; Gordon C; Stone MB
    J Neurosurg Spine; 2015 Jan; 22(1):15-25. PubMed ID: 25380538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activL(®) Artificial Disc: a next-generation motion-preserving implant for chronic lumbar discogenic pain.
    Yue JJ; Garcia R; Miller LE
    Med Devices (Auckl); 2016; 9():75-84. PubMed ID: 27274317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.
    Blumenthal S; McAfee PC; Guyer RD; Hochschuler SH; Geisler FH; Holt RT; Garcia R; Regan JJ; Ohnmeiss DD
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1565-75; discussion E387-91. PubMed ID: 16025024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of lumbar total disc replacement using ProDisc-L in degenerative disc disease: minimum 5-year follow-up results at a single institute.
    Park CK; Ryu KS; Lee KY; Lee HJ
    Spine (Phila Pa 1976); 2012 Apr; 37(8):672-7. PubMed ID: 21857395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial discs for lumbar and cervical degenerative disc disease -update: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(10):1-98. PubMed ID: 23074480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total disc replacement surgery for symptomatic degenerative lumbar disc disease: a systematic review of the literature.
    van den Eerenbeemt KD; Ostelo RW; van Royen BJ; Peul WC; van Tulder MW
    Eur Spine J; 2010 Aug; 19(8):1262-80. PubMed ID: 20508954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH; Schranck FW; Copay AG
    J Neurosurg Spine; 2019 May; 31(3):347-356. PubMed ID: 31100723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.